Perhaps the most radical infrastructure planning changes this year were in Wales, with the legal framework for the wholesale reform of its infrastructure consenting process introduced in The ...
Etteplan Oyj's Board of Directors has today approved the company's renewed strategy and updated financial targets for the years 2025-2027. Both will come into effect on January 1, 2025.
The majority of Teva's business lies in generic and off-patent branded drugs and faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...
Andrea Kleiner is to become the new Head of Business Clients at Baloise in Switzerland on 1 April 2025, joining the Executive Committee. She is taking over from Executive Committee member ...
Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process Committed to Full Continuity in Delivering Next-Generation BAW ...